Standard BioTools Pre-Tax Profit Margin 2010-2024 | LAB
Standard BioTools pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Standard BioTools Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-09-30 |
$0.16B |
$-0.13B |
-80.13% |
| 2024-06-30 |
$0.14B |
$-0.12B |
-87.50% |
| 2024-03-31 |
$0.13B |
$-0.09B |
-70.87% |
| 2023-12-31 |
$0.11B |
$-0.08B |
-70.75% |
| 2023-09-30 |
$0.11B |
$-0.08B |
-72.38% |
| 2023-06-30 |
$0.11B |
$-0.09B |
-80.19% |
| 2023-03-31 |
$0.10B |
$-0.13B |
-137.11% |
| 2022-12-31 |
$0.10B |
$-0.19B |
-194.95% |
| 2022-09-30 |
$0.11B |
$-0.18B |
-165.45% |
| 2022-06-30 |
$0.11B |
$-0.17B |
-147.79% |
| 2022-03-31 |
$0.13B |
$-0.12B |
-96.00% |
| 2021-12-31 |
$0.13B |
$-0.06B |
-48.09% |
| 2021-09-30 |
$0.14B |
$-0.07B |
-50.72% |
| 2021-06-30 |
$0.15B |
$-0.06B |
-40.94% |
| 2021-03-31 |
$0.14B |
$-0.06B |
-39.58% |
| 2020-12-31 |
$0.14B |
$-0.05B |
-38.85% |
| 2020-09-30 |
$0.13B |
$-0.05B |
-38.89% |
| 2020-06-30 |
$0.11B |
$-0.06B |
-50.89% |
| 2020-03-31 |
$0.11B |
$-0.06B |
-50.88% |
| 2019-12-31 |
$0.12B |
$-0.07B |
-56.90% |
| 2019-09-30 |
$0.12B |
$-0.07B |
-59.48% |
| 2019-06-30 |
$0.12B |
$-0.07B |
-59.66% |
| 2019-03-31 |
$0.12B |
$-0.07B |
-61.54% |
| 2018-12-31 |
$0.11B |
$-0.06B |
-54.46% |
| 2018-09-30 |
$0.11B |
$-0.06B |
-51.85% |
| 2018-06-30 |
$0.10B |
$-0.06B |
-54.81% |
| 2018-03-31 |
$0.10B |
$-0.06B |
-57.84% |
| 2017-12-31 |
$0.10B |
$-0.06B |
-62.14% |
| 2017-09-30 |
$0.10B |
$-0.07B |
-74.00% |
| 2017-06-30 |
$0.10B |
$-0.08B |
-79.38% |
| 2017-03-31 |
$0.10B |
$-0.08B |
-78.22% |
| 2016-12-31 |
$0.10B |
$-0.08B |
-77.88% |
| 2016-09-30 |
$0.11B |
$-0.07B |
-67.27% |
| 2016-06-30 |
$0.12B |
$-0.06B |
-54.70% |
| 2016-03-31 |
$0.12B |
$-0.06B |
-50.85% |
| 2015-12-31 |
$0.12B |
$-0.06B |
-48.28% |
| 2015-09-30 |
$0.12B |
$-0.06B |
-46.61% |
| 2015-06-30 |
$0.12B |
$-0.06B |
-50.42% |
| 2015-03-31 |
$0.12B |
$-0.06B |
-49.15% |
| 2014-12-31 |
$0.12B |
$-0.06B |
-50.43% |
| 2014-09-30 |
$0.11B |
$-0.05B |
-49.52% |
| 2014-06-30 |
$0.09B |
$-0.04B |
-44.09% |
| 2014-03-31 |
$0.08B |
$-0.03B |
-37.80% |
| 2013-12-31 |
$0.07B |
$-0.02B |
-23.94% |
| 2013-09-30 |
$0.07B |
$-0.02B |
-24.24% |
| 2013-06-30 |
$0.06B |
$-0.02B |
-26.23% |
| 2013-03-31 |
$0.06B |
$-0.02B |
-29.82% |
| 2012-12-31 |
$0.05B |
$-0.02B |
-37.74% |
| 2012-09-30 |
$0.05B |
$-0.02B |
-38.00% |
| 2012-06-30 |
$0.05B |
$-0.02B |
-39.58% |
| 2012-03-31 |
$0.05B |
$-0.02B |
-45.65% |
| 2011-12-31 |
$0.04B |
$-0.02B |
-47.73% |
| 2011-09-30 |
$0.04B |
$-0.02B |
-51.22% |
| 2011-06-30 |
$0.04B |
$-0.02B |
-52.63% |
| 2011-03-31 |
$0.04B |
$-0.02B |
-51.43% |
| 2010-12-31 |
$0.03B |
$-0.02B |
-51.52% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.562B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
